Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2016-01-21
|
NeuVax™ (nelipepimut-S) |
HER2 gastric cancer |
observational |
Galena Biopharma (USA - OR) Dr Reddy's laboratories (India) |
Cancer - Oncology |
2016-01-21
|
Viberzi® (US)/Truberzii® (UE) (eluxadoline) |
irritable bowel syndrome with diarrhea (IBS-D) |
3 |
Allergan (Ireland) |
Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
2016-01-21
|
darleukin (L19- IL2) and fibromun (L19-TNF?) |
melanoma |
3 |
Philogen (Italy) |
Cancer - Oncology |
2016-01-20
|
IMCgp100, durvalumab (MEDI4736) and tremelimumab |
melanoma |
1-2 |
Immunocore (UK) MedImmune (USA - global biologics arm of AstraZeneca (UK) Inovio Pharmaceuticals (USA - PA) |
Cancer - Oncology |
2016-01-19
|
rapastinel (GLYX-13) |
major depressive disorder (MDD) |
preclinical |
Allergan (Ireland) |
Mental diseases - CNS diseases |
2016-01-19
|
NRL-1 (intranasal diazepam) |
epilepsy patients who experience acute repetitive seizures |
|
Neurelis (USA - CA) |
Rare diseases - CNS diseases |
2016-01-19
|
GLPG2222 |
cystic fibrosis |
1 |
Galapagos (Belgium) |
Rare diseases - Genetic diseases |
2016-01-19
|
AssureMDx™ for bladder cancer |
bladder cancer |
|
MDxHealth (Belgium) |
Cancer - Oncology - Diagnostic |
2016-01-16
|
ConfirmMDx® for Prostate Cancer test |
prostate cancer |
|
MDxHealth (Belgium) |
Cancer - Oncology - Diagnostic |
2016-01-14
|
FF-21101 |
solid tumors |
1 |
Fujifilm Corporation (Japan) |
Cancer - Oncology |
2016-01-14
|
TV003 |
dengue fever |
3 |
Butantan Institute (Brazil) |
Infectious diseases |
2016-01-14
|
MK-7243 (Grazax® in Europe - grass allergy immunotherapy tablet) |
grass pollen allergic rhinoconjunctivitis |
3 |
ALK Abello (Denmark) |
Allergic diseases - Inflammatory diseases - Respiratory diseases |
2016-01-13
|
Xtandi® (enzalutamide) |
metastatic castration-resistant prostate cancer (mCRPC) |
2 |
Medivation (USA - CA) Astellas (Japan) |
Cancer - Oncology |
2016-01-13
|
IONIS-HBV-LRx |
hepatitis B |
1 |
GSK (UK) Ionis Pharmaceuticals (USA - CA) |
Infectious diseases |
2016-01-12
|
exosome nanomedicine platform |
|
preclinical |
Reneuron (UK) |
|
2016-01-11
|
dipraglurant |
Parkinson's disease levodopa-induced dyskinesia (PD-LID) |
2a |
Addex Therapeutics (Switzerland) |
Neurodegenerative diseases - CNS diseases |
2016-01-11
|
CAR architecture |
|
|
Cellectis (France) |
|
2016-01-11
|
DNA ImmunoBody® vaccine SCIB1 |
Stage III/IV malignant melanoma |
1-2 |
Scancell Holdings (UK) |
Cancer - Oncology |
2016-01-11
|
laquinimod |
Huntington's disease |
2 |
Teva Pharmaceutical (Israel) Active Biotech (Sweden) |
Genetic diseases - Neurodegenerative diseases - Rare diseases |
2016-01-11
|
Sleeping Beauty transposon-transposase system |
|
|
Ziopharm Oncology (USA - MA) |
Cancer - Oncology |